Serum Institute fixes price of covid vaccine Covishield in private, state government hospitals
Premium
Share Via
Read Full Story
Serum Institue of India (SII) has fixed the price of Covishield vaccine at ₹600 per dose for private hospitals and ₹400 per jab for state governments, Serum Institute of India chief executive Adar Poonawalla said in a statement on Wednesday.
Serum Institue said the company will serve 50% of the total production to the Government of India s vaccination program, and the remaining 50% of the capacity will be for the State governments and private hospitals.
TRENDING STORIESSee All
1 min read
Premium
1 min read
Premium
1 min read
What seemed like a never-ending plea has finally been put to rest with the new vaccines. Thanks to the scientists working endlessly, we finally have many vaccinations available in the market against the novel coronavirus. India too is not behind in the race of COVID-19 vaccines. In fact, the country has regulated two vaccines, Covishield and Covaxin.
The Oxford-AstraZeneca vaccine, Covishield, is being manufactured by the Serum Institute of India (SII), the world’s largest vaccine manufacturer. After Covishield, the pharmaceutical giant is all set to launch Covavax by June this year, suggests media reports. The new vaccine shall be launched under the brand name of Covavax, which SII is manufacturing in partnership with Novovax.